Retinal imaging: A new tool for studying underlying liability to cardiovascular disease in schizophrenia

Madeline Meier, Melanie L. Hill, Nicholas J K Breitborde

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Despite evidence that individuals with schizophrenia are disproportionately affected by cardiovascular and cerebrovascular diseases, it is unclear if individuals with schizophrenia have an underlying liability to cardiovascular diseases or if these diseases are a consequence of psychotic illness (e.g., antipsychotic medications, sedentary lifestyle). To resolve this, we must study cardiovascular disease risk factors in individuals in the early stages of illness with limited exposure to antipsychotic medications (i.e., individuals with first-episode psychosis) and in unaffected relatives of individuals with schizophrenia. Here we review evidence of cardiovascular risk in individuals with first-episode psychosis and in unaffected relatives of individuals with schizophrenia. We identify a gap in research on cardiovascular risk in these populations, namely the lack of studies that directly visualize the vasculature, and we introduce a novel technology, retinal imaging, that may be useful for directly visualizing the vasculature and clarifying pathophysiological mechanisms that underlie both schizophrenia and cardiovascular disease. We conclude with suggestions for priorities in future research using retinal imaging.

Original languageEnglish (US)
Pages (from-to)326-334
Number of pages9
JournalCurrent Psychiatry Reviews
Volume12
Issue number4
DOIs
StatePublished - Dec 1 2016

Fingerprint

Schizophrenia
Cardiovascular Diseases
Psychotic Disorders
Antipsychotic Agents
Sedentary Lifestyle
Cerebrovascular Disorders
Technology
Research
Population

Keywords

  • Glucose
  • Inflammatory
  • Psychosis
  • Retinal imaging
  • Schizophrenia
  • Vascular

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Retinal imaging : A new tool for studying underlying liability to cardiovascular disease in schizophrenia. / Meier, Madeline; Hill, Melanie L.; Breitborde, Nicholas J K.

In: Current Psychiatry Reviews, Vol. 12, No. 4, 01.12.2016, p. 326-334.

Research output: Contribution to journalReview article

@article{3e129ed947304361bbc32c288062c0b3,
title = "Retinal imaging: A new tool for studying underlying liability to cardiovascular disease in schizophrenia",
abstract = "Despite evidence that individuals with schizophrenia are disproportionately affected by cardiovascular and cerebrovascular diseases, it is unclear if individuals with schizophrenia have an underlying liability to cardiovascular diseases or if these diseases are a consequence of psychotic illness (e.g., antipsychotic medications, sedentary lifestyle). To resolve this, we must study cardiovascular disease risk factors in individuals in the early stages of illness with limited exposure to antipsychotic medications (i.e., individuals with first-episode psychosis) and in unaffected relatives of individuals with schizophrenia. Here we review evidence of cardiovascular risk in individuals with first-episode psychosis and in unaffected relatives of individuals with schizophrenia. We identify a gap in research on cardiovascular risk in these populations, namely the lack of studies that directly visualize the vasculature, and we introduce a novel technology, retinal imaging, that may be useful for directly visualizing the vasculature and clarifying pathophysiological mechanisms that underlie both schizophrenia and cardiovascular disease. We conclude with suggestions for priorities in future research using retinal imaging.",
keywords = "Glucose, Inflammatory, Psychosis, Retinal imaging, Schizophrenia, Vascular",
author = "Madeline Meier and Hill, {Melanie L.} and Breitborde, {Nicholas J K}",
year = "2016",
month = "12",
day = "1",
doi = "10.2174/1573400512666160927145417",
language = "English (US)",
volume = "12",
pages = "326--334",
journal = "Current Psychiatry Reviews",
issn = "1573-4005",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

TY - JOUR

T1 - Retinal imaging

T2 - A new tool for studying underlying liability to cardiovascular disease in schizophrenia

AU - Meier, Madeline

AU - Hill, Melanie L.

AU - Breitborde, Nicholas J K

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Despite evidence that individuals with schizophrenia are disproportionately affected by cardiovascular and cerebrovascular diseases, it is unclear if individuals with schizophrenia have an underlying liability to cardiovascular diseases or if these diseases are a consequence of psychotic illness (e.g., antipsychotic medications, sedentary lifestyle). To resolve this, we must study cardiovascular disease risk factors in individuals in the early stages of illness with limited exposure to antipsychotic medications (i.e., individuals with first-episode psychosis) and in unaffected relatives of individuals with schizophrenia. Here we review evidence of cardiovascular risk in individuals with first-episode psychosis and in unaffected relatives of individuals with schizophrenia. We identify a gap in research on cardiovascular risk in these populations, namely the lack of studies that directly visualize the vasculature, and we introduce a novel technology, retinal imaging, that may be useful for directly visualizing the vasculature and clarifying pathophysiological mechanisms that underlie both schizophrenia and cardiovascular disease. We conclude with suggestions for priorities in future research using retinal imaging.

AB - Despite evidence that individuals with schizophrenia are disproportionately affected by cardiovascular and cerebrovascular diseases, it is unclear if individuals with schizophrenia have an underlying liability to cardiovascular diseases or if these diseases are a consequence of psychotic illness (e.g., antipsychotic medications, sedentary lifestyle). To resolve this, we must study cardiovascular disease risk factors in individuals in the early stages of illness with limited exposure to antipsychotic medications (i.e., individuals with first-episode psychosis) and in unaffected relatives of individuals with schizophrenia. Here we review evidence of cardiovascular risk in individuals with first-episode psychosis and in unaffected relatives of individuals with schizophrenia. We identify a gap in research on cardiovascular risk in these populations, namely the lack of studies that directly visualize the vasculature, and we introduce a novel technology, retinal imaging, that may be useful for directly visualizing the vasculature and clarifying pathophysiological mechanisms that underlie both schizophrenia and cardiovascular disease. We conclude with suggestions for priorities in future research using retinal imaging.

KW - Glucose

KW - Inflammatory

KW - Psychosis

KW - Retinal imaging

KW - Schizophrenia

KW - Vascular

UR - http://www.scopus.com/inward/record.url?scp=85012050863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012050863&partnerID=8YFLogxK

U2 - 10.2174/1573400512666160927145417

DO - 10.2174/1573400512666160927145417

M3 - Review article

AN - SCOPUS:85012050863

VL - 12

SP - 326

EP - 334

JO - Current Psychiatry Reviews

JF - Current Psychiatry Reviews

SN - 1573-4005

IS - 4

ER -